Why This Comparison Matters
Tesamorelin, sermorelin, and ipamorelin are the three GH peptides most frequently prescribed by anti-aging clinics and most commonly used in the research community. They represent three different approaches to GH optimization — and understanding how they differ helps you choose the right one (or combination) for your goals.
The fundamental distinction: Tesamorelin and sermorelin are GHRH pathway peptides (they tell the pituitary to produce GH). Ipamorelin is a ghrelin pathway peptide (it tells the pituitary to release GH). They’re not interchangeable — they’re complementary.
Head-to-Head Comparison
| Feature | Tesamorelin | Sermorelin | Ipamorelin |
|---|---|---|---|
| Pathway | GHRH receptor | GHRH receptor | Ghrelin receptor (GHS-R1a) |
| Function | Amplifies GH production | Amplifies GH production | Triggers GH release |
| FDA status | Approved (Egrifta SV) | Orphan drug (Geref — discontinued) | Not approved |
| Half-life | ~26 minutes | ~10 minutes | ~2 hours |
| GH potency | High | Low-moderate | Moderate |
| IGF-1 increase | 30–80% | 15–30% | 20–40% |
| Visceral fat data | Phase 3 (18% VAT reduction) | Limited | None |
| Cortisol effect | None | None | None |
| Prolactin effect | None | None | None |
| Appetite effect | None | None | Minimal |
| Desensitization | Moderate | Moderate | Minimal |
| Dosing | 2 mg once daily | 200–300 mcg once daily | 200–300 mcg 1–3x daily |
| Route | Subcutaneous | Subcutaneous | Subcutaneous |
| Best timing | Pre-sleep, fasted | Pre-sleep, fasted | Pre-sleep, fasted (or post-workout) |
| Pharma cost | $500–1,000/mo | $150–300/mo (clinic) | N/A (not pharmaceutical) |
| Research cost | $150–300/mo | $50–100/mo | $50–100/mo |
| Clinic availability | Prescription required | Some clinics | Many clinics (with CJC-1295) |
Understanding the Two Pathways
GHRH Pathway: Tesamorelin & Sermorelin
Both tesamorelin and sermorelin bind the GHRH receptor on the anterior pituitary. They tell somatotroph cells to produce growth hormone — synthesize it, store it, prepare it for release. Think of them as the “volume knob” that determines how much GH is available.
Tesamorelin vs Sermorelin:
- Tesamorelin has a trans-3-hexenoic acid modification that extends its biological activity (~26 min half-life vs ~10 min for sermorelin)
- Tesamorelin produces greater IGF-1 elevation (30–80% vs 15–30%)
- Tesamorelin has Phase 3 data specifically demonstrating visceral fat reduction
- Tesamorelin is significantly more expensive
- Both show moderate receptor desensitization with continuous daily use
Ghrelin Pathway: Ipamorelin
Ipamorelin binds the ghrelin receptor (GHS-R1a) on the anterior pituitary. It triggers the release of stored GH — the GH that GHRH peptides helped produce. Think of it as the “trigger” that fires the GH pulse.
Why ipamorelin specifically: Ipamorelin is the most selective GHRP (growth hormone releasing peptide) available. Unlike GHRP-2, GHRP-6, and hexarelin, ipamorelin does not significantly raise cortisol, prolactin, or ACTH at standard doses. It has minimal appetite stimulation and shows little desensitization with sustained use.
The Synergy Principle
Combining one peptide from each pathway (GHRH + GHRP) produces synergistic GH release — 3–5x greater than either alone. This is why peptide clinics prescribe combinations:
| Combination | GH Output | Clinical Use |
|---|---|---|
| Sermorelin + Ipamorelin | Moderate-high | Most common anti-aging clinic combo |
| CJC-1295 + Ipamorelin | High | Most common research community combo |
| Tesamorelin + Ipamorelin | Very high (theoretical) | Less commonly used |
| Tesamorelin alone | High | FDA-approved standalone |
| MK-677 alone | High (sustained) | Oral convenience, no injection |
Choosing Your Protocol
Decision Framework
“I want the strongest evidence and don’t mind cost.” → Tesamorelin — FDA-approved, Phase 3 visceral fat data, strongest GHRH analog
“I want the standard clinic protocol.” → Sermorelin + Ipamorelin — widely prescribed, long clinical history, well-tolerated
“I want the best cost-performance ratio.” → CJC-1295 + Ipamorelin via Growth Hormone Stack — more potent than sermorelin, research-grade pricing
“I don’t want to inject.” → MK-677 — oral, once daily, strong GH elevation (accept hunger and glucose effects)
“I specifically want visceral fat reduction.” → Tesamorelin — the only GH peptide with CT-verified visceral fat data
“I want the safest, most conservative option.” → Sermorelin — longest clinical track record, self-limiting (somatostatin feedback intact), very low side effect profile
By Goal
| Goal | Best Protocol | Rationale |
|---|---|---|
| Anti-aging / longevity | Sermorelin + Ipamorelin or CJC-1295 + Ipamorelin | Clean pulsatile GH, long-term safety |
| Body recomposition | CJC-1295 + Ipamorelin (3x daily) | Maximum pulsatile GH for fat oxidation |
| Visceral fat specifically | Tesamorelin 2 mg/day | Only option with Phase 3 VAT data |
| Sleep optimization | Any pre-sleep protocol | All GH peptides enhance deep sleep |
| Injury recovery | CJC-1295 + Ipamorelin + BPC-157 | GH accelerates repair; BPC-157 targets tissue |
| Budget-conscious | MK-677 10 mg oral | $30–60/mo, no injection supplies |
| Competition / tested sport | None | All GH secretagogues are WADA-prohibited |
Cost Comparison
Monthly Cost at Standard Dosing
| Protocol | Clinic | Research-Grade |
|---|---|---|
| Tesamorelin 2 mg/day | $500–1,000 | $150–300 |
| Sermorelin 300 mcg/day | $200–400 | $50–100 |
| Ipamorelin 300 mcg/day | N/A | $50–100 |
| Sermorelin + Ipamorelin | $300–500 | $100–200 |
| CJC-1295 + Ipamorelin | N/A | $100–200 |
| MK-677 10 mg/day | N/A | $30–60 |
Total Cycle Cost (3-Month Protocol)
| Protocol | Clinic (3 months) | Research (3 months) |
|---|---|---|
| Tesamorelin alone | $1,500–3,000 | $450–900 |
| Sermorelin + Ipamorelin | $900–1,500 | $300–600 |
| CJC-1295 + Ipamorelin | N/A | $300–600 |
| MK-677 alone | N/A | $90–180 |
Side Effect Comparison
All three peptides are well-tolerated. The differences are minor but worth noting:
| Side Effect | Tesamorelin | Sermorelin | Ipamorelin |
|---|---|---|---|
| Injection-site reaction | Common (24%) | Common | Common |
| Joint pain | Common (13%) | Rare | Rare |
| Peripheral edema | Common (6%) | Rare | Rare |
| Headache | Occasional | Occasional | Rare |
| Hyperglycemia | Possible | Rare | Rare |
| Flushing | Rare | Occasional | Rare |
Tesamorelin has the most side effects because it produces the strongest GH elevation. Higher GH = more GH-related effects (water retention, joint stiffness, glucose changes).
Related Protocols
- Tesamorelin Protocol — FDA-approved GHRH analog
- Sermorelin Protocol — the original GH peptide
- Ipamorelin Protocol — the cleanest GHRP
- CJC-1295 Protocol — research-grade GHRH alternative
- MK-677 Protocol — oral GH secretagogue
- Growth Hormone Stack — CJC-1295 + Ipamorelin combination
- GH Peptides Compared — all GH options compared
Frequently Asked Questions
Which is better, sermorelin or ipamorelin? +
They work through different receptor pathways and are designed to be used together, not chosen between. Sermorelin stimulates GH production (GHRH pathway). Ipamorelin triggers GH release (ghrelin pathway). Combining them produces 3–5x more GH than either alone. If you must choose one: ipamorelin is cleaner (no cortisol/prolactin effects), sermorelin has a longer clinical track record.
Is tesamorelin stronger than sermorelin? +
Yes. Tesamorelin produces greater GH elevation and has specific clinical data for visceral fat reduction (18% VAT reduction in Phase 3 trials). It is the only GHRH analog with full FDA approval. However, tesamorelin is significantly more expensive ($500–1,000/month pharmaceutical vs $50–100/month research-grade sermorelin) and available only by prescription.
Can I combine tesamorelin with ipamorelin? +
Theoretically yes — they target different receptors (GHRH vs ghrelin). However, this is not a well-studied combination. Most practitioners pair sermorelin or CJC-1295 with ipamorelin instead, as these combinations have more clinical use data. Tesamorelin's higher potency means the additive benefit of ipamorelin may be less significant.
Which GH peptide is cheapest? +
Research-grade pricing: MK-677 ($30–60/month, oral) is cheapest overall. Among injectables, sermorelin and ipamorelin are similar ($50–100/month each). Tesamorelin is most expensive at pharmaceutical pricing ($500–1,000/month) or $150–300/month research-grade. CJC-1295 is similar to sermorelin in cost.
Do I need a prescription for these GH peptides? +
Tesamorelin (Egrifta) requires a prescription. Sermorelin was previously available by prescription but Geref was discontinued — some clinics still prescribe compounded sermorelin. Ipamorelin is not FDA-approved and is available only as a research chemical or through compounding pharmacies. CJC-1295 + Ipamorelin combinations are commonly available through anti-aging clinics.